패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Heska Corporation 14 애널리스트 중 3 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Benjamin Haynor	Alliance Global Partners
Raymond Myers	Benchmark Company
Kara Anderson	B. Riley Securities, Inc.

This company has been acquired

Heska 대차 대조표 상태

재무 상태 기준 확인 4/6

주요 정보

최근 재무 상태 업데이트

Is Heska (NASDAQ:HSKA) A Risky Investment?

Is Heska (NASDAQ:HSKA) A Risky Investment?

Heska (NASDAQ:HSKA) Has A Rock Solid Balance Sheet

Is Heska (NASDAQ:HSKA) A Risky Investment?

Is Heska (NASDAQ:HSKA) A Risky Investment?

Recent updates

Heska Corporation(NasdaqCM:HSKA) dropped from NASDAQ Composite Index

Antech Diagnostics, Inc. completed the acquisition of Heska Corporation (NasdaqCM:HSKA) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc. and others.

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target increased by 22% to US$130

Full year 2022 earnings: EPS misses analyst expectations

Heska Corporation to Report Q4, 2022 Results on Feb 28, 2023

Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

Heska Corporation Announces Nancy Wisnewski Step Downs as Executive Vice President and Chief Operating Officer, Effective March 31, 2023

Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 50%?

Heska Corporation (NasdaqCM:HSKA) acquired MBio Diagnostics, Inc.

Price target decreased to US$123

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Heska Corporation Provides Earnings Guidance for the Year 2022

Heska Corporation to Report Q3, 2022 Results on Nov 08, 2022

Heska Corporation (NasdaqCM:HSKA) entered a definitive agreement to acquire MBio Diagnostics, Inc. for $38.7 million.

Heska Corporation (NasdaqCM:HSKA) entered a definitive agreement to acquire MBio Diagnostics, Inc. for $38.7 million.

Heska to acquire LightDeck Diagnostics for $38.7M

Executive VP & COO exercised options to buy US$880k worth of stock.

Is Heska (NASDAQ:HSKA) A Risky Investment?

Consensus forecasts updated

Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 31%?

Heska Corporation Provides Revenue Guidance for the Year 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Heska Non-GAAP EPS of $0.34 misses by $0.03, revenue of $64.7M misses by $3.76M

Consensus EPS estimates fall by 28%

Heska Corporation to Report Q2, 2022 Results on Aug 08, 2022

Heska Corporation(NasdaqCM:HSKA) dropped from Russell 2000 Growth-Defensive Index

Heska Corporation Provides Consolidated Revenue Guidance for the Year 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Is Heska (NASDAQ:HSKA) A Risky Investment?

Price target decreased to US$195

Heska Corporation to Report Q1, 2022 Results on May 09, 2022

Heska Corporation (NASDAQ:HSKA) Shares Could Be 50% Below Their Intrinsic Value Estimate

Heska Corporation, Annual General Meeting, May 04, 2022

Executive VP & CFO exercised options and sold US$81k worth of stock

Executive VP recently sold US$97k worth of stock

Price target decreased to US$199

What Is Heska Corporation's (NASDAQ:HSKA) Share Price Doing?

Full year 2021 earnings: EPS exceeds analyst expectations

Heska Corporation Provides Earnings Guidance for the Full Year 2022

Price target decreased to US$219

Director exercised options to buy US$1.1m worth of stock.

CEO, President & Director exercised options to buy US$5.7m worth of stock.

Consensus forecasts updated

Heska Corporation to Report Q4, 2021 Results on Feb 28, 2022

Now 21% undervalued after recent price drop

Consensus forecasts updated

Heska (NASDAQ:HSKA) Has A Rock Solid Balance Sheet

Heska Corporation (NasdaqCM:HSKA) completed the acquisition of VetZ GmbH.

Estimating The Fair Value Of Heska Corporation (NASDAQ:HSKA)

CEO, President & Director recently bought US$173k worth of stock

CEO, President & Director recently bought US$179k worth of stock

Price target decreased to US$246

What Does Heska Corporation's (NASDAQ:HSKA) Share Price Indicate?

Executive VP & COO exercised options to buy US$1.9m worth of stock.

Third quarter 2021 earnings released

Is Heska (NASDAQ:HSKA) A Risky Investment?

Heska Corporation (NasdaqCM:HSKA) acquired an unknown majority stake in Biotech Laboratories U.S.A. LLC.

CEO, President & Director notifies of intention to sell stock

Independent Director exercised options and sold US$477k worth of stock

Executive VP & COO recently sold US$270k worth of stock

Executive VP & CFO exercised options and sold US$952k worth of stock

Heska Corporation Revises Earnings Guidance for the Year 2021

Second quarter 2021 earnings released: US$0.056 loss per share (vs US$0.72 loss in 2Q 2020)

Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?

Is Heska (NASDAQ:HSKA) A Risky Investment?

Heska Corporation(NasdaqCM:HSKA) dropped from Russell Microcap Growth Index

Executive VP & COO recently sold US$989k worth of stock

Calculating The Intrinsic Value Of Heska Corporation (NASDAQ:HSKA)